19 May 2013
Keywords: intermune, dips, follow-up, study, data, updated, results
Article | 13 January 2003
Updated results from InterMune's Phase III trial of Actimmune(interferon gamma) in patients with idiopathic pulmonary fibrosis
suggest that some ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 June 2003
17 May 2013
© 2013 thepharmaletter.com